IRADIMED CORP (IRMD) Forecast, Price Target & Analyst Ratings

NASDAQ:IRMD • US46266A1097

Current stock price

93.4 USD
-2.16 (-2.26%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IRADIMED CORP (IRMD).

Forecast Snapshot

Consensus Price Target

Price Target
$121.04
+ 29.59% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 24, 2026
Period
Q1 / 2026
EPS Estimate
$0.45
Revenue Estimate
21.741M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$121.04
Upside
+ 29.59%
From current price of $93.40 to mean target of $121.04, Based on 8 analyst forecasts
Low
$117.16
Median
$122.40
High
$126.00

Price Target Revisions

1 Month
0.00%
3 Months
21.21%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for IRMD. The average price target is 121.04 USD. This implies a price increase of 29.59% is expected in the next year compared to the current price of 93.4.
The average price target has been revised upward by 21.21% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

IRMD Current Analyst RatingIRMD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

IRMD Historical Analyst RatingsIRMD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
IRMD was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IRMD.
In the previous month the buy percentage consensus was at a similar level.
IRMD was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-02-14Roth MKMReiterate Buy -> Buy
2024-08-02Roth MKMMaintains Buy -> Buy
2024-04-22Roth MKMReiterate Buy
2021-08-02Roth CapitalMaintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 24, 2026
Period
Q1 / 2026
EPS Estimate
$0.45
Revenue Estimate
21.741M
Revenue Q2Q
11.43%
EPS Q2Q
8.07%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
2.52%
EPS (1 Month)
0.00%
EPS (3 Months)
-3.26%

Next Earnings Summary

IRMD is expected to report earnings on 4/24/2026. The consensus EPS estimate for the next earnings is 0.45 USD and the consensus revenue estimate is 21.74M USD.
The next earnings revenue estimate has been revised upward by 2.52% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
IRMD revenue by date.IRMD revenue by date.
65.562M
23.01%		73.242M
11.71%		83.814M
14.43%		93.86M
11.99%		103.16M
9.91%		N/A
EBITDA
YoY % growth
IRMD ebitda by date.IRMD ebitda by date.
20.801M
27.61%		22.782M
9.53%		27.313M
19.89%		30.396M
11.29%		36.516M
20.13%		42.738M
17.04%
EBIT
YoY % growth
IRMD ebit by date.IRMD ebit by date.
20.036M
28.19%		21.965M
9.63%		26.147M
19.04%		30.99M
18.52%		34.805M
12.31%		N/A
Operating Margin
IRMD operating margin by date.IRMD operating margin by date.
30.56%29.99%31.20%33.02%33.74%N/A
EPS
YoY % growth
IRMD eps by date.IRMD eps by date.
1.48
35.78%		1.65
11.49%		1.92
16.36%		2.12
10.50%		2.37
11.54%		2.72
15.09%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		0.45
8.07%		0.47
-3.20%		0.56
18.28%		0.63
16.17%
Revenue
Q2Q % growth		21.741M
11.43%		21.557M
5.62%		24.194M
14.11%		26.266M
15.75%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		6.453M
18.81%		6.786M
-0.03%		8.354M
22.25%		9.449M
33.20%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

IRMD Yearly Revenue VS EstimatesIRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
IRMD Yearly EPS VS EstimatesIRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

IRADIMED CORP / IRMD Forecast FAQ

What do analysts expect the price target to be for IRADIMED CORP (IRMD)?

8 analysts have analysed IRMD and the average price target is 121.04 USD. This implies a price increase of 29.59% is expected in the next year compared to the current price of 93.4.

Can you provide the upcoming earnings date for IRADIMED CORP?

IRADIMED CORP (IRMD) will report earnings on 2026-04-24.

What are the consensus estimates for IRMD stock next earnings?

The consensus EPS estimate for the next earnings of IRADIMED CORP (IRMD) is 0.45 USD and the consensus revenue estimate is 21.74M USD.

What is the consensus rating for IRMD stock?

The consensus rating for IRADIMED CORP (IRMD) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.